---
$id: https://graph.org.ai/products/commodity/51112002
$type: Product
source: UNSPSC
code: "51112002"
title: "Dasatinib"
class: "51112000"
classTitle: "Tyrosine kinase inhibitors"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dasatinib

**UNSPSC Code**: 51112002
**Class**: [Tyrosine kinase inhibitors](Tyrosine kinase inhibitors.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a tyrosine kinase inhibitor with the molecular formula C22H26ClN7O2S.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RBZ1571X5H, chemically known as 5-thiazolecarboxamide, n-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)- but generally known as dasatinib, which bears US NIH Compound Identifier 3062316. European Medicines Agency schedules Dasatinib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB23322. World Health Organization schedules dasatinib in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule dasatinib under HS 29341000 and SITC 51579. As of Q4 2014, DASATINIB remains the US FDA Preferred Term for this commodity. Dasatinib bears US NLM identifiers UMLS ID C1455147 and NCI Concept Code C38713. SMILES: CLC1C(NC(=O)C2SC(NC3NC(NC(N4CCN(CC4)CCO)C3)C)NC2)C(CCC1)C.

